| Literature DB >> 30541483 |
Nicola Adams1, Dawn A Skelton2, Denise Howel3, Cathy Bailey4, Rosy Lampitt5, Tony Fouweather3, Joanne Gray4, Dorothy Coe4, Jennifer Wilkinson5, Sheena Gawler4, Lex D de Jong6, Heather Waterman7, Vincent Deary4, Michael Clarke8, Steve W Parry9.
Abstract
BACKGROUND: Visually impaired older people (VIOP) have a higher risk of falling than their sighted peers, and are likely to avoid physical activity. The aim was to adapt the existing Falls Management Exercise (FaME) programme for VIOP, delivered in the community, and to investigate the feasibility of conducting a definitive randomised controlled trial (RCT) of this adapted intervention.Entities:
Keywords: Exercise; Falls management; Feasibility clinical trial; Older people; Visual impairment
Mesh:
Year: 2018 PMID: 30541483 PMCID: PMC6292024 DOI: 10.1186/s12877-018-0998-6
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Trial Procedures
| Intervention | Control | |
|---|---|---|
| Weeks 1–12 | Daily completion of falls diary | Daily completion of falls diary |
| Week 12 ((+/− 2 weeks) | Following information collected: | Information collected as per intervention group |
| Weeks 12–24 | Daily completion of falls diary | Information collected as per intervention group. |
| Week 24 (+/− 2 weeks) | Assessed on all measures | Assessed on all measures |
Fig. 1Schematic Representation of the Randomised Controlled Trial
Fig. 2CONSORT Diagram of the VIOLET Study
Baseline demographic characteristics, by treatment arm
| Variable | Intervention Arm ( | Usual activities Arm ( |
|---|---|---|
| Gender | ||
| Male | 14 (42%) | 11 (35%) |
| Female | 19 (58%) | 20 (65%) |
| Age (years) | ||
| Median (IQR) | 80 (75, 87) | 78 (68, 83) |
| Mean (SD) | 79.3 (8.7) | 76.5 (9.7) |
| Range | 61–95 | 62–95 |
| Participants’ first language: | ||
| English | 32 (97%) | 28 (90%) |
| Other | 1 (3%) | 3 (10%) |
| Ethnicity | ||
| White | 33 (100%) | 29 (94%) |
| Asian or Asian British | 0 (0%) | 2 (6%) |
| Marital status: | ||
| Married/living as married | 16 (48%) | 8 (26%) |
| Living with other family members | 0 (0%) | 2 (6%) |
| Living alone | 11 (33%) | 16 (52%) |
| Widowed | 6 (18%) | 5 (16%) |
| Employment status | ||
| Full time employment | 0 (0%) | 1 (3%) |
| Retired | 29 (88%) | 28 (90%) |
| Other | 4 (12%) | 2 (6%) |
Baseline numbers of self-reported co-morbidities, by treatment arm
| Comorbidities | Intervention Arm ( | Usual activities Arm ( | Total | |
|---|---|---|---|---|
| Any comorbidities reported | Yes | 25 (76%) | 20 (65%) | 45 (70%) |
| No | 8 (24%) | 11 (35%) | 19 (30%) | |
| Numbers of comorbidities per participant | Min | 0 | 0 | 0 |
| LQ | 1 | 0 | 0 | |
| Median | 2 | 2 | 2 | |
| UQ | 5 | 6 | 5 | |
| Max | 9 | 13 | 13 |
Summary statistics for the exercise classes attended and home exercise
| min | LQ | Median | UQ | max | |
|---|---|---|---|---|---|
| Number classes attended | 0 | 9 | 10 | 12 | 12 |
| Weeks when exercised at home during interventiona | 0 | 5 | 9 | 11 | 14 |
| Average weekly exercise frequencyb | 0 | 1.8 | 3.4 | 4.6 | 6.7 |
| Average exercise duration per week (min)b | 0 | 17.3 | 50.4 | 75.7 | 122 |
a ‘during intervention’ is any calls made in the period between 1st exercise class and last class + 7 days
b is the average frequency or duration for all weeks when participant reported exercising at home in the valid timeframe (note that these include zeros for weeks where no exercise at home was done)
Numeric outcome measures by trial arm and data collection point (weeks 0, 12 & 24)
| Week | Intervention arm | Usual activities arm | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | min | LQ | Med | UQ | max | n | min | LQ | Med | UQ | max | ||
| SFES-I | 0 | 32 | 7 | 8 | 9 | 10 | 15 | 31 | 7 | 7 | 9 | 11 | 23 |
| 12 | 29 | 7 | 8 | 9 | 11 | 14 | 30 | 7 | 7 | 8 | 10 | 20 | |
| 24 | 28 | 7 | 7 | 8 | 10 | 21 | 31 | 7 | 7 | 8 | 11 | 17 | |
| Impact of visual impairment (WSAS) | 0 | 32 | 0 | 5.6 | 11.9 | 18.1 | 27.5 | 30 | 0 | 5.0 | 12.5 | 23.8 | 38.8 |
| 12 | 29 | 0 | 10 | 15 | 20 | 35 | 31 | 0 | 3.8 | 11.3 | 17.5 | 37.5 | |
| 24 | 28 | 0 | 12.5 | 20 | 25.6 | 40 | 31 | 0 | 5 | 15 | 26.3 | 33.8 | |
| Falls risk assessment tool | 0 | 33 | 0 | 0 | 1 | 3 | 5 | 31 | 0 | 1 | 1 | 3 | 4 |
| 12 | 29 | 0 | 1 | 1 | 3 | 4 | 31 | 0 | 1 | 2 | 3 | 4 | |
| 24 | 28 | 0 | 1 | 1 | 3 | 4 | 31 | 0 | 1 | 2 | 3 | 4 | |
| Phone-FITT | 0 | 33 | 0 | 34 | 49 | 89.5 | 296 | 31 | 1 | 16 | 42.5 | 66 | 222 |
| 12 | 29 | 0 | 41 | 55 | 96 | 209 | 31 | 0 | 25 | 47 | 67 | 377 | |
| 24 | 28 | 9 | 30.8 | 52.1 | 100.5 | 410 | 31 | 0 | 18 | 43 | 66 | 1506 | |
| Functional test | 0 | 33 | 8.8 | 9.8 | 13.3 | 16.8 | 35.6 | 31 | 7.4 | 10.7 | 13.3 | 20 | 120 |
| 12 | 28 | 8.9 | 11 | 13.5 | 18.4 | 30.2 | 31 | 6 | 11.1 | 17 | 19.2 | 975 | |
| 24 | 28 | 8.2 | 10.3 | 13.8 | 16.3 | 28.5 | 31 | 6.6 | 10.4 | 15.1 | 18.2 | 100 | |
Costing of intervention
| Resource use | Cost (£) | Unit | Source |
|---|---|---|---|
| Costs of Consumables | |||
| Yoga Mats and exercise bands | 420 | Total cost | VIOLET study files |
| DVDs and CDs | 65 | Total cost | VIOLET study files |
| Costs of Staff Time | |||
| Newcastle PSI (12 sessions × 3 cycles) | 66.66 | Per hour | HealthWorks |
| Glasgow PSI (12 sessions X 2 cycles) | 61.50 | Per hour | LLT |
| Glasgow PSI set up time (0.5 h per session for 24 sessions) | 30.75 | Per 30 mins | LLT |
| Glasgow PSI travel and parking costs (per session) | 7.24 | Per session | LLT |
| Costs of Room Hire and Refreshments | |||
| Newcastle (3 × 12 week cycles) | 1925 | Total Cost | HealthWorks |
| Glasgow (2 × 12 week cycles) | 1476 | Total Cost | Visibility |
KEY: PSI postural stability instructor, LLT Later Life Training
EQ-5D-5 L utility scores and ICECAP-O for health-related quality of life by trial arm
| Intervention Arm | Usual Activities Arm | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) | Median (IQR) | Range | N | Mean (SD) | Median (IQR) | Range | |
| EQ-5D-5 L Utility Scores | ||||||||
| Baseline | 28 | −0.23 (0.25) | −0.25 (0.39) | 0.83 | 31 | −0.15 (0.24) | −0.19 (0.18) | 1.15 |
| 12 weeks | 28 | −0.2 (0.22) | −0.2 (0.29) | 0.78 | 31 | −0.12 (0.27) | −0.15 (0.35) | 0.95 |
| 24 weeks | 28 | −0.21 (0.27) | −0.26 (0.47) | 0.9 | 31 | −0.06 (0.28) | −0.09 (0.43) | 1.14 |
| ICECAP-O Capability Scores | ||||||||
| Baseline | 27 | 0.79 (0.14) | 0.84 (0.22) | 0.46 | 31 | 0.77 (0.12) | 0.77 (0.2) | 0.43 |
| 12 weeks | 27 | 0.8 (0.11) | 0.82 (0.13) | 0.46 | 31 | 0.8 (0.13) | 0.83 (0.19) | 0.48 |
| 24 weeks | 27 | 0.8 (0.14) | 0.83 (0.14) | 0.67 | 31 | 0.78 (0.15) | 0.82 (0.24) | 0.54 |
Summary of issues raised and implications for a future definitive trial
| Issues | Findings | Implications for future trial |
|---|---|---|
| Identifying potential participants | a) Via third sector organisations | Would need to support third sector staff more |
| Did eligible participants consent? | 66/68 (97%) of those eligible consented to enter trial: exceeded target of 50% | Unreliable estimate from this pilot trial |
| Met recruitment target? | Randomised 64 participants to trial: below target of 80 | Recruitment was more difficult than anticipated: need to improve procedures |
| Compliance with intervention | 25/33 (76%) completed at least 9/12 group sessions: exceeded target of 70% | Compliance with exercise class regime is possible |
| Home exercise duration per week | Median duration 50 min: encouraged to exercise for 120 min | Need to find ways of encouraging participants to exercise at home for longer |
| Intervention | FaME intervention successfully adapted for VIOP | Need exercises appropriate to ability of individual, providing sufficient challenge |
| Retention throughout study | 59 participants retained to end of study: narrowly missed target of 60 | Retention was better than anticipated |
| Outcome assessments completed | 60/64 (94%) provided data at 12 week visit | Once recruited, retention and data collection was very good. No problem with completion if researchers can help, but this is time-consuming |
| Suitability of candidate outcome measures | Suitable, howeverelements of standard assessments were occasionally inappropriate for VIOP | Other outcome assessments may additionally be included. |
| Safety issues? | 16 serious adverse events, but none deemed due to intervention: less than target of < 10% | No safety issues |
| Sample size calculation for definitive trial | Calculation very imprecise because of lack of estimates of parameters for SFES-1 | Better estimates necessary |
| Data collection for health economic analysis | Data often missing from resources form | Data collection form needs to be more structured |